中文速读
本研究使用Entranster-in vivo体内转染siRNA敲低CDK9,在C57BL/6小鼠内毒素血症模型中证明CDK9抑制可减轻炎症和细胞坏死/焦亡,改善生存率。
小鼠肝肺siRNATHP-1primary mouse bone marrow-derived macrophages
本文使用:慢病毒感染增强试剂Envirus™-LV
Cyclin-Dependent Kinase 9 Inhibition Suppresses Necroptosis and Pyroptosis in the Progress of Endotoxemia
Jiao Li 1 2 , Huimin Mao 2 , Yue Pan 2 , Houxuan Li 3 , Lang Lei 4 Affiliations
- PMID: 32556803
- DOI: 10.1007/s10753-020-01274-1
Abstract
The host innate immune response stands at the first line of defense against the outburst of pathogen invasion and their byproduct release. The balanced and coordinated expression of genes in normal immune responses is compromised in the progress of endotoxemia with exacerbated inflammation and massive cell death. In the present study, we identified cyclin-dependent kinase 9 (CDK9), the functional subunit of the positive transcription elongation factor b, as a master regulator of inflammatory gene transcription in the process of promoter-proximal pausing to productive elongation. Therapeutic pharmacological inhibition of CDK9 by flavopiridol (FVD) rescued mice from death in experimental models of fatal endotoxemia. In addition to alleviation of the cytokine storm in the circulation system following lethal endotoxin injection, FVD treatment significantly dampened the onset of inflammation in the livers and lungs and reduced the necroptosis and pyroptosis in livers. Moreover, CDK9 inhibition reduced inflammatory cytokine release and decreased cell death in the pro-inflammatory pyroptotic and necroptotic cell death pathway in monocytes in responses to lipopolysaccharide. In conclusion, CDK9 inhibition may affect the progress of endotoxemia by dampening inflammation and cell death including necroptosis and pyroptosis.
Keywords: cell death; cyclin-dependent kinase 9; endotoxemia; inflammation.
慢病毒感染增强试剂Envirus™-LV 已有 27 篇已发表文献
同类研究
- Exp Hematol Oncol. 2026 Aug 14;15(1):118.doi: 10.1186/s40164-026-00818-9. Targeting SLC6A14-mediated nutrient competitio…
- Stem Cell Res Ther. 2025 May 1;16(1):216.doi: 10.1186/s13287-025-04300-x. DSUP modified mesenchymal stem cells exert sig…
- Cytotechnology. 2024 Dec 1;77(1):10.doi: 10.1007/s10616-024-00671-w. KDM1A-mediated ZFP64 demethylation activates CENPL…
- Cell Rep Med. 2024 Oct 15;5(10):101731.doi: 10.1016/j.xcrm.2024.101731. Epub 2024 Sep 19. Reprograming immunosuppressive…
- Biomed Res Int. 2022 Jul 12;2022:7850658.doi: 10.1155/2022/7850658. eCollection 2022. SLC6A14 Depletion Contributes to A…